市场调查报告书
商品编码
1439506
手术缝线 - 全球市场回顾、竞争格局、市场预测 (2030)Surgical Sutures - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球手术缝线市场规模将于 2023 年达到 35.6 亿美元,到 2030 年将达到 52.4 亿美元,预计在 2024-2030 年预测期内复合年增长率为 6.64%。 手术缝线需求的增加主要是由于全球手术数量的增加。 此外,这些因素还包括需要手术治疗的疾病数量的增加,例如关节炎、脊柱畸形和癌症、非致命伤害的增加、产品批准的扩大以及各种先进手术缝合线的推出。预计将在预测期内加强对缝合线的需求并导致市场扩张。
手术缝线市场动态
由于世界各地外科手术的增加,外科缝线市场目前正在成长动能。 例如,根据全球外科基金会2023年发布的数据,全球约30%的各种适应症引起的疾病可以透过手术治疗。
此外,根据世界卫生组织(WHO)2023年发布的统计数据,全球剖腹产率持续上升,占所有新生儿的21%以上。 报告称,这一数字预计将进一步增加,到 2030 年,剖腹产将占所有分娩的约 29%。
因此,手术数量的增加预计将有助于未来几年手术缝线市场的整体成长。
此外,用于有效闭合手术部位的先进缝合线的推出预计也将在未来几年推动手术缝合线市场的发展。 例如,2020年6月17日,强生医疗器材公司旗下医疗器材公司DePuy Synthes在欧洲市场推出了DYNACORD缝合线,旨在用于肩袖修復中的软组织近似等手术。它已在某些部分发布。 与其他可能鬆动的高强度骨科手术缝线不同,DYNACORD 缝线经过专门设计,可在压迫时缩短,从而最大限度地减少间隙形成。
因此,所有上述因素预计将在预测期内扩大手术缝合线市场。
然而,闭合手术部位和手术伤口的替代装置的出现以及手术缝合线严格的监管审批程序可能会在未来几年抑制全球手术缝合线市场。
此外,史无前例的 COVID-19 大流行已在早期阶段减缓了全球手术缝线市场的发展。 全国范围内的封锁、为防止感染传播而取消和拒绝择期手术、跨境物流限制导致的供应链中断等正在导致手术缝线市场成长放缓。 根据世界卫生组织 (WHO) 2023 年发布的脉搏调查,约 90% 的国家仍报告基本卫生服务出现一项或多项中断。 约 20% 的国家可能挽救生命的急诊和外科护理仍然受到干扰,反映出这场流行病最直接的间接影响。 此外,三分之二的国家报告暂停了择期手术,随着疫情的持续,其影响正在累积。 然而,由于2020年下半年全球多种COVID-19疫苗的批准和管理,包括医疗保健服务在内的各个领域的活动恢復情况有了显着改善,从而促进了外科手术的增长缝合线市场健康復苏的道路已经铺平。
手术缝合线市场细分分析
在手术缝线产品类型细分市场中,缝线类别在预测期内占据了很大份额。 缝线有子类别:可吸收缝线和不可吸收缝线。 可吸收缝合线的广泛使用是促进市场成长的因素之一。
此外,随着时间的推移溶解的好处同时为伤口闭合提供足够的拉伸强度也增加了其需求。
本报告研究和分析了全球手术缝合线市场,提供市场规模和预测、驱动因素和挑战、公司和产品概况等。
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable And Non Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), by geography, is expected to grow at a significant CAGR forecast till 2030 owing to the increasing surgical procedures across the globe and launch of advanced surgical sutures in the market
The global surgical sutures market was valued at USD 3.56 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 5.24 billion by 2030. The increase in demand for surgical sutures is predominantly attributed to the rise in the volume of surgeries worldwide. Moreover, an increase in various diseases such as arthritis, spinal deformities, cancers, among others which require surgery for their management, a rise in non-fatal injuries, growing approval of products, and launches of various advanced surgical sutures are anticipated to bolster the demand for these sutures thereby leading to an increase in the global market for surgical sutures during the forecasted period.
Surgical Sutures Market Dynamics:
The market for surgical sutures is gaining momentum at present owing to the increase in surgical procedures across the globe. For instance, as per the data published by the Global Surgery Foundation in the year 2023, there are approximately 30% of global disorders caused by various indications can be treated by surgery.
Furthermore, according to the statistics published by the World Health Organization (WHO) in the year 2023, the rate of caesarean section continues to rise globally accounting for more than 21% of all childbirths. As per the report, the number is anticipated to increase and approximately 29% of all births would likely take place by caesarean section by 2030.
Thus, growing surgeries would contribute to the growth of the overall surgical sutures market in the upcoming years.
In addition, the launch of advanced sutures for an efficient closure of the surgical site is also expected to boost the surgical sutures market in the forthcoming years. For instance, on June 17, 2020, DePuy Synthes, the Johnson & Johnson Medical Devices Companies, launched DYNACORD Suture intended to be used in procedures such as soft tissue approximation in rotator cuff repairs in select European markets. Unlike other high-strength orthopaedic sutures which may experience laxity, DYNACORD Suture is specifically designed to shorten when compression is lost, thereby minimizing gap formation.
Hence, all the above-mentioned factors are projected to augment the market for surgical sutures during the forecasted period.
However, the availability of alternative devices for closing the surgical sites and surgery wounds, and stringent regulatory approval process for the surgical sutures is likely to impede the global surgical sutures market in the upcoming years.
In addition, the unprecedented COVID-19 outbreak has slowed down the global market for surgical sutures during the initial phases. Nationwide lockdown, cancelled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of surgical sutures. According to the World Health Organization "pulse survey" published in the year 2023, about 90% of countries are still reporting one or more disruptions to essential health services. Potentially life-saving emergency, critical, and surgical care interventions are still disrupted in about 20% of countries, reflecting the most immediate indirect consequences of the pandemic. Two-thirds of countries also report disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the surgical sutures market.
Surgical Sutures Market Segment Analysis:
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the surgical sutures product type segment, the suture thread category accounted for a significant share during the forecasted period. The suture thread is sub-categorized into absorbable and non - absorbable types. The wide availability of absorbable sutures is one of the factors for increased market growth.
In addition, the advantage of providing sufficient tensile strength for wound closure, while dissolving over time has increased their demand.
Moreover, recommendations by the governmental organization for the use of technologically advanced absorbable surgical sutures would also bolster the demand in the upcoming years. For instance, on June 28, 2022, National Institute for Health and Care Excellence (NICE) has issued new medical technologies guidance (MTG) recommending the use of Plus Sutures developed by Ethicon, a medical device division of Johnson & Johnson, in surgeries within the National Health Service (NHS). Plus Sutures are a range of synthetic, absorbable sutures that are either impregnated with or coated with medical-grade triclosan, a broadspectrum antibacterial agent effective on most common organisms associated with surgical site infection (SSI).
Hence the aforementioned factors are likely to contribute to the market growth in the forthcoming years.
North America is expected to dominate the overall Surgical Sutures Market:
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period. This domination is owing to the rise in various diseases such as bone deformities, cancer, among others leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
For instance, as per the Centers for Disease Control and Prevention 2022 data, in the US, approximately 24% of all adults, or 58.5 million people, have arthritis in 2020. Moreover, as per the annual report released by the American Joint Replacement Registry (AJRR) in the year 2020, as of July 1, 2020, approximately 2 million hip and knee arthroplasty procedures were performed.
Furthermore, as per the Canadian Institute for Health Information 2022 data, in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed and the demand for both the replacement surgeries continues to increase. Thus, the rise in surgeries as a treatment option for the various disorders would contribute to the surgical sutures market.
Moreover, approval of surgical sutures in the region is also one of the factors responsible for the growth of the surgical sutures during the forecasted period. For instance, in July 2020, SM ENG CO., LTD, received the US FDA approval for its surgical suture, REXSIN (a synthetic absorbable PGA suture) indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures.
Also, in October 2020, FDA gave clearance to StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice developed by Origami Surgical.
Thus, the interplay of all the factors in the region is expected to propel the regional surgical sutures market in the forthcoming years.
Additionally, the Asia-pacific region has the future potential for the surgical sutures market. This is due to the rising number of surgeries such as cardiac surgery, caesarean surgery, among others in the region. For instance, as per the 2019 statistics revealed by the Australian Institute of Health and Welfare, about 24% (2.7 million) of the hospital admissions in the country involved elective surgery in the year 2017-2018. Furthermore, improving healthcare structure, rise in disposable incomes, and presence of regional market players such as Gunze Limited, Meril Lifesciences, among others will also contribute to the market growth of surgical sutures in the forthcoming years.
Surgical Sutures Market Key Players:
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmaceutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., ORIGAMI SURGICAL LLC, and others.
Recent Developmental Activities in the Surgical Sutures Market:
On November 24, 2020, Healthium Medtech Limited launched TRUBARB, an absorbable surgical needled suture and a polydioxanone knotless tissue-closure device with a triangular end-stopper.
On November 24, 2020, LSI Solutions, Inc. received FDA approval for RAM® COR-SUTURE® QUICK LOAD® Surgical Suture and COR-SUTURE® QUICK LOAD® Surgical Suture intended for use in the approximation of soft tissue and prosthetic materials.
On September 09, 2020, Smith+Nephew launched HEALICOIL(TM) KNOTLESS Suture Anchor, expanding its revolutionary line of Advanced Healing Solutions for rotator cuff repair.
Key Takeaways from the Surgical Sutures Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Surgical Sutures market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Surgical Sutures Market.
Various opportunities available for the other competitor in the Surgical Sutures Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Surgical Sutures market growth in the coming future?
Target Audience who can be benefited from the Surgical Sutures Market Report Study
Surgical Sutures providers
Research organizations and consulting companies
Surgical Sutures-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Surgical Sutures
Various End-users who want to know more about the Surgical Sutures Market and the latest technological developments in the Surgical Sutures market.
Frequently Asked Questions for the Surgical Sutures Market:
A surgical suture is one of the most common medical devices used by doctors during surgeries. The suture helps in holding body tissues together after a surgery or an injury. The application of a suture essentially involves the use of a needle along with an attached thread.
The global surgical sutures market was valued at USD 3.56 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 5.24 billion by 2030.
The major factors driving the demand for Surgical Sutures are the rising surgical procedures across the globe. In addition, an increase in diseases such as coronary artery diseases, neurovascular disorders, among others which require surgical intervention, a rise in falls and injuries, the launch of various advanced surgical sutures, among others are likely to drive the market during the forecasted period.
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmaceutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., and others.
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period, 2024-2030. This domination is owing to the rise in chronic diseases leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.